FNIP2

FNIP2 is a cytoplasmic scaffolding protein that heterodimerizes with folliculin (FLCN) through paired Longin and DENN domains and connects nutrient sensing to mTORC1 activation and AMPK-dependent stress signaling. The FLCN–FNIP2 heterodimer functions as a GTPase-activating protein (GAP) for RagC/D GTPases—using a conserved FLCN arginine finger—to promote lysosomal recruitment and activation of mTORC1 in response to amino acids (PMID:31704029, PMID:37772772). FNIP2 also participates in an FLCN–AMPK complex that mediates O6-methylguanine-triggered, MLH1-dependent AMPK activation and mitochondrial apoptosis, and it interacts with the SERCA2b calcium channel to modulate cytoplasmic calcium availability and mitochondrial respiration (PMID:22209521, PMID:41771847). Loss-of-function mutation of FNIP2 in dogs causes CNS hypomyelination due to defective oligodendrocyte maturation, establishing an in vivo requirement for this gene in myelination (PMID:24272703).

1. 2008 High

   Identifying FNIP2 as a direct FLCN- and AMPK-binding partner established that a second folliculin-interacting protein exists and that BHD-associated FLCN truncations disrupt this interaction, framing FNIP2 within the tumor-suppressor pathway.

   Evidence Reciprocal co-immunoprecipitation and yeast two-hybrid in two independent labs with deletion mutant mapping

   PMID:18403135 PMID:18663353

   Open questions at the time

   • Stoichiometry and competitive versus cooperative binding between FNIP1 and FNIP2 on FLCN not resolved
   • Whether FNIP2 has FLCN-independent functions was untested
2. 2008 Medium

   Demonstrating that FNIP2 retains FLCN in the cytoplasm and that knockdown of FNIP1/FNIP2 reduces S6K1 phosphorylation placed the FLCN–FNIP2 complex upstream of mTORC1 signaling.

   Evidence Fluorescence microscopy with truncation mutants and siRNA knockdown with pS6K1 western blot

   PMID:18663353

   Open questions at the time

   • Whether FNIP2-dependent cytoplasmic retention is the mechanism of mTORC1 regulation or an independent function was unclear
   • Single-lab observation without independent replication at the time
3. 2009 Medium

   Showing that FNIP2 loss suppresses O6-methylguanine-induced apoptosis without affecting upstream DNA damage checkpoints positioned FNIP2 as a dedicated mediator between mismatch-repair signaling and mitochondrial cell death.

   Evidence Gene-trap mutagenesis and siRNA in MNU-treated cells with mitochondrial membrane potential and caspase-3 readouts

   PMID:19137017

   Open questions at the time

   • Direct target of FNIP2 in the apoptotic cascade was unidentified
   • Relevance outside alkylating-agent context not tested
4. 2011 Medium

   Linking FNIP2 and FLCN to MLH1-dependent AMPKα phosphorylation after O6-methylguanine damage identified AMPK activation as the specific step requiring FNIP2 in the apoptotic pathway.

   Evidence siRNA knockdown of FNIP2 and FLCN with pAMPKα western blot and AICAR stimulation

   PMID:22209521

   Open questions at the time

   • Mechanism by which FNIP2 facilitates AMPK phosphorylation (scaffold vs. conformational) was unknown
   • Whether this AMPK-dependent function is separable from mTORC1 regulation was not addressed
5. 2012 Medium

   Establishing that FLCN stabilizes FNIP2 while AMPK binding promotes its proteasomal degradation revealed a reciprocal regulatory loop controlling FNIP2 protein levels during stress.

   Evidence Cycloheximide chase, MG132 treatment, and co-IP after siRNA knockdown of FLCN or AMPKα

   PMID:23201403

   Open questions at the time

   • Ubiquitin ligase responsible for FNIP2 degradation was not identified
   • Post-translational modification sites on FNIP2 mediating stability changes were unmapped
6. 2014 Medium

   A natural canine FNIP2 frameshift mutation causing CNS hypomyelination demonstrated an in vivo requirement for FNIP2 in oligodendrocyte maturation, extending its biological roles beyond cancer signaling.

   Evidence GWAS, gene sequencing, and CNS histopathology in affected dogs

   PMID:24272703

   Open questions at the time

   • Molecular mechanism linking FNIP2 to oligodendrocyte differentiation was not determined
   • Whether mTORC1 or AMPK dysregulation underlies the myelination defect was untested
7. 2019 High

   The cryo-EM structure of the FLCN–FNIP2–Rag–Ragulator complex resolved the molecular basis of nutrient-dependent mTORC1 activation: FLCN and FNIP2 heterodimerize via Longin and DENN domain pairs, and FLCN contributes a catalytic arginine finger for RagC/D GAP activity.

   Evidence Cryo-EM structure determination with biochemical GAP assays and arginine-finger mutagenesis

   PMID:31704029

   Open questions at the time

   • Conformational transitions that release FLCN–FNIP2 from the lysosome upon nutrient withdrawal were not captured
   • Whether FNIP2 contributes catalytic residues beyond the scaffold role was not addressed
8. 2023 Medium

   Identifying MEF2A/D-driven and SRC-enhanced transcriptional control of FNIP2 revealed how oncogenic signaling in pancreatic cancer amplifies FLCN–FNIP2 GAP activity to hyperactivate mTORC1.

   Evidence ChIP, siRNA/shRNA, phospho-mutagenesis, lysosomal fractionation, and mTORC1 activity assays in pancreatic cancer cells

   PMID:37772772

   Open questions at the time

   • Whether MEF2-SRC regulation of FNIP2 operates in non-cancer contexts was unknown
   • Relative contribution of FNIP2 versus FNIP1 in this transcriptional program was not dissected
9. 2026 Medium

   Discovery of a direct FNIP2–SERCA2b interaction showed that FNIP2 restrains cytoplasmic calcium availability; its loss boosts mitochondrial respiration and glucose consumption, linking FNIP2 to calcium-dependent metabolic control.

   Evidence Co-IP of FNIP2–SERCA2b, FNIP2 knockout, metabolomics, flux analysis, and electron tomography in Ataxia Telangiectasia cells

   PMID:41771847

   Open questions at the time

   • Whether FNIP2 modulates SERCA2b enzymatic activity or simply sequesters it is unresolved
   • Generalizability beyond ATM-deficient cells not demonstrated
   • Relationship between SERCA2b binding and FLCN–FNIP2 complex formation is undefined

• Key unresolved questions include whether FNIP2 has catalytic contributions to GAP activity beyond scaffolding, the identity of the E3 ligase controlling FNIP2 turnover, the molecular pathway through which FNIP2 loss impairs oligodendrocyte maturation, and whether FNIP2's calcium-regulatory and mTORC1 functions are mechanistically coupled.
• No structural data on FNIP2-specific catalytic residues in GAP reaction
• E3 ubiquitin ligase for FNIP2 degradation unknown
• Mechanism linking FNIP2 to oligodendrocyte differentiation undefined
• Whether SERCA2b and Rag–Ragulator interactions are mutually exclusive or concurrent is untested